I was not aware that Avandia was the #2 seller for GSK. This is really going to hurt for them:
(Reuters) – European officials moved to pull GlaxoSmithKline’s diabetes drug Avandia off the market and U.S. authorities imposed tight restrictions over heart risks, effectively spelling the commercial end to the once-lucrative medicine.
Once a top treatment choice and Glaxo’s No. 2 seller, the rulings attempted to resolve a bitter, three-year debate over Avandia’s safety that has dogged the reputation of the medicine and its maker, and divided staff inside the U.S. Food and Drug Administration.
The question I have is whether the FDA’s new actions are sufficient to trigger a new statute of limitations for people who want to file an Avandia lawsuit. Traditionally, when the FDA adds a black box warning or recalls a drug, that acts as sufficient information to trigger a new statute under the discovery rule. Regardless, I’m sure that this will trigger a new wave of Avandia lawsuits.